A tumor cell-targeted nanogel, a preparation method thereof, and a tumor cell-targeted nanogel drug-loaded particle

A tumor cell and nanogel technology, which is applied in the field of tumor cell-targeted nanogel drug-loaded particles, can solve the problems of poor biocompatibility, large drug side effects, poor water solubility and stability, and achieve biocompatibility Good sex, inhibit tumor, prolong the effect of blood circulation time

Active Publication Date: 2017-06-23
CHANGCHUN INST OF APPLIED CHEMISTRY - CHINESE ACAD OF SCI
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the antitumor drugs used in clinical chemotherapy have no selective killing of normal tissue cells while killing cancer cells. Therefore, the drugs have large toxic and side effects, and the antitumor drugs have poor water solubility and stability during application. Defects such as poor biocompatibility limit the application of tumor drugs in the treatment of cancer

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A tumor cell-targeted nanogel, a preparation method thereof, and a tumor cell-targeted nanogel drug-loaded particle
  • A tumor cell-targeted nanogel, a preparation method thereof, and a tumor cell-targeted nanogel drug-loaded particle
  • A tumor cell-targeted nanogel, a preparation method thereof, and a tumor cell-targeted nanogel drug-loaded particle

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0031] The invention provides a method for preparing a tumor cell-targeted nanogel, comprising the following steps:

[0032] A) dissolving the initiator with phenylboronic acid group and L-glutamic acid oligoethylene glycol monomethyl ether-N-cyclic acid anhydride in an organic solvent to react to obtain a mixed solution;

[0033] B) mixing the compound having the structure of formula (I) and the compound having the structure of formula (II) with the mixed solution obtained in step A), and reacting to obtain a reaction solution;

[0034] C) mixing the reaction solution obtained in step B) with an organic solvent, and filtering to obtain a tumor cell-targeted nanogel;

[0035]

[0036] In the invention, firstly, the initiator with phenylboronic acid group and L-glutamic acid oligoethylene glycol monomethyl ether-N-cyclic acid anhydride are dissolved in an organic solvent for reaction to obtain a mixed solution.

[0037] Wherein, the initiator has a phenylboronic acid group,...

Embodiment 1～5

[0079] The preparation of embodiment 1~5L-glutamic acid oligoethylene glycol monomethyl ether ester

[0080] 20mL of ethylene glycol monomethyl ether, 40mL of diethylene glycol monomethyl ether, 60mL of triethylene glycol monomethyl ether, 80mL of tetraethylene glycol monomethyl ether and 100mL of pentaethylene glycol monomethyl ether Stir and mix with 10g of L-glutamic acid, add concentrated sulfuric acid dropwise, and react while stirring. After the reaction, adjust the solution to neutral, centrifuge to obtain a solid, dissolve the solid with methanol, pour it into isopropanol, centrifuge to obtain a solid, and dry it in vacuum to obtain L-glutamic acid oligoethylene glycol monomethyl ether ester. See Table 1 for specific yields, and Table 1 shows the yields of L-glutamic acid oligoethylene glycol monomethyl ether esters prepared in Examples 1-5.

[0081] Table 1 The yield of L-glutamic acid oligoethylene glycol monomethyl ether prepared in Examples 1 to 5 (please supplem...

Embodiment 6～10

[0083] The preparation of embodiment 6~10L-glutamic acid oligoethylene glycol monomethyl ether ester-N-cyclic acid anhydride

[0084] Mix 1 g of L-glutamic acid oligoethylene glycol monomethyl ether ester described in Examples 1 to 5 with 0.6 g of bis(trichloromethyl)carbonate at 25° C., add tetrahydrofuran, and heat to React at 50°C for 2 hours. After the reaction, settle the reaction mixture in excess petroleum ether, separate, wash, recrystallize and dry to obtain L-glutamic acid oligoethylene glycol monomethyl ether ester-N-cyclic anhydride . See Table 2 for specific yields, and Table 2 shows the yields of L-glutamic acid oligoethylene glycol monomethyl ether ester-N-cyclic anhydride prepared in Examples 6-10.

[0085] Table 2 Yield of L-glutamic acid oligoethylene glycol monomethyl ether ester-N-cyclic acid anhydride prepared in Examples 6-10 (please supplement the yield in Table 2)

[0086] product Yield / %

[0087] Example 6 L-glutamic ac...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a kind of preparation method of the nano gel of tumor cell targeting, comprises the following steps: A) the initiator with phenylboronic acid group and L-glutamic acid oligomer glycol monomethyl ether-N The acid anhydride in the ring is dissolved in an organic solvent and reacted to obtain a mixed solution; B) the compound with the structure of formula (I) and the compound with the structure of formula (II) are mixed with the mixed solution obtained in step A) and reacted to obtain Reaction solution; C) mixing the reaction solution obtained in step B) with an organic solvent, and filtering to obtain a tumor cell-targeted nanogel; using the tumor cell-targeted nanogel drug-loaded particles provided by the present invention is non-toxic to the human body Side effects, and has good water solubility, stability and biocompatibility.

Description

technical field [0001] The invention belongs to the technical field of polymer drug carriers, and in particular relates to a tumor cell-targeted nanogel, a preparation method thereof, and a tumor cell-targeted nanogel drug-loaded particle. Background technique [0002] Tumor has become one of the most serious diseases threatening human health. Commonly used clinical cancer treatment methods include surgery, radiation therapy and chemotherapy. [0003] Among them, surgery is the treatment of choice for early-stage cancer. Surgical treatment of cancer is to remove all or part of the cancer tissue, and the effect is direct and rapid. However, surgery cannot completely remove cancer cells, and cannot eliminate small lesions, and only palliative local resection can be done for cancer patients that have metastasized. In addition, due to the damage to the body caused by the operation, the patient's immunity will be reduced, and a series of complications are prone to occur after ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C08J3/075C08G69/42A61K47/10A61K9/06A61P35/00
Inventor 丁建勋陈进进庄秀丽陈学思
Owner CHANGCHUN INST OF APPLIED CHEMISTRY - CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap